SCHEMBL21687602

SCHEMBL21687602

N#Cc1ccc(-c2cccc(-n3c4ccccc4c4ccccc43)c2)cc1[Si](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 2/20 0.40
KDM4E B2RXH2 3/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
THRB P10828 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
HIF1A Q16665 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687496 0.93 ALDH1A1 (0.36) ALDH1A1LMNASMN1; SMN2HPGDMAPK1
SCHEMBL21687987 0.91 ATM (0.38) ALDH1A1LMNASMN1; SMN2HPGDMAPK1
SCHEMBL21687446 0.91 KDM4E (0.40) ALDH1A1LMNASMN1; SMN2HPGDMAPK1
SCHEMBL21687967 0.90 KDM4E (0.41) ALDH1A1LMNASMN1; SMN2HPGDMAPK1
SCHEMBL21687459 0.89 KDM4E (0.39) ALDH1A1LMNASMN1; SMN2HPGDMAPK1
SCHEMBL21688197 0.89 ALDH1A1 (0.38) ALDH1A1LMNASMN1; SMN2HPGDMAPK1
SCHEMBL21687739 0.88 KDM4E (0.35) ALDH1A1LMNASMN1; SMN2HPGDMAPK1
SCHEMBL21687783 0.87 PGR (0.35) ALDH1A1LMNASMN1; SMN2HPGDMAPK1
SCHEMBL21688107 0.87 KDM4E (0.37) ALDH1A1LMNASMN1; SMN2HPGDMAPK1
SCHEMBL21688117 0.87 ALDH1A1 (0.40) ALDH1A1LMNASMN1; SMN2HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 ALDH1A1 616/4885LMNA 1582/4885SMN1; SMN2 4039/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 ALDH1A1 616/4885LMNA 1582/4885SMN1; SMN2 4039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.